Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

What it means for patients - The compounded versions of the drug were originally sold to combat a brand-name shortage ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...

With the growing popularity of weight loss medications, many people are turning to prescription options to help them achieve their health goals. Medications like Ozempic, Mounjaro, and Wegovy are ...

Research out this week might help you plan your own version of ... Ozempic and the higher-dose obesity drug Wegovy.

along with diet and exercise. With off-label use, doctors prescribe a drug for a use that the FDA has not approved. Wegovy is FDA approved to help weight loss and long-term weight management in ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

The plans are not final ... to its roots about diet and exercise. On the other hand, a traditional diet program focusing on mindful eating may be a thing of the past as many Americans are turning to ...